22 04 27 apopro

CS MEDICA announces additional product availability on Apopros webshop and on shelves at Matas 186 medicare stores

CS MEDICA (”CS MEDICA” or the ”Company”) announces today that the CANNASEN® CBD products Pain Patch, Protective nasal gel, PSOR + ATOPIC lotion has been launched on Apopro’s Webshop and are now available for online sales. The Company also announces the CANNASEN®CBD Protective nasal gel has been launched on Matas and is now available on shelves in 186 medicare stores. Previous product availability on Matas includes the medical devices CANNASEN®CBD Arthritis Gel, Psoriasis Gel, Anti-Hair Loss Serum and Hand Cream

Following the monthly CEO letter published on April 7, 2022, CS MEDICA today provides an update on previously expected agreements and CANNASEN® CBD product releases. The Company is experiencing a growing interest in its product line, among others originating from its planned post-marketing clinical trials in local disease organizations. As of April 2022, CS MEDICA has more than 500 sales channels in the Nordic area.

CS MEDICA has been focused on extending the Company’s product availability on new and already established sales channels to be able to sell and distribute CANNANSEN products. The Company has been selling medical devices on the following webshops in Denmark: matas.dk, webapoteket.dk, apopro.dk, med24.dk, dinapoteker.dk and their own web shop cosmage.dk. As of Apopro, CS Medica currently has the CANNASEN®CBD Arthritis Gel, Psoriasis Gel, and the CBD Anti-Hairloss Serum listed. Today, the Company announces that three additional have been launched on Apopro. The additional products are available on Apopro’s webshop and include CANNASEN® CBD products Pain Patch, Protective nasal gel, PSOR + ATOPIC lotion. To increase awareness and sales of the Cannasen brand via ApoPro CS Medica will launch a Cannasen landing page on ApoPro app. week 19 followed by a newsletter promoting the Cannasen brand and the full assortment to the ApoPro customer club.

Today, the Company also announces extended product availability in Matas physical medicare stores. As expected in the latest CEO letter, CS Medica has launched its CANNASEN® CBD Protective nasal gel on Matas shelves at 186 medicare stores. Other CANNASEN® CBD products available on Matas webshop and medicare stores include Arthritis Gel, Psoriasis Gel, Pain Patch, Protective Nasal Gel, and CBD PSOR+ATOPIC Lotion. Matas is a nationwide retail company that offers a wide range of beauty and health products as well as over-the-counter medicines. There are almost 250 Matas stores throughout Denmark, of which the above CANNASEN products are present at their medicare stores, a total of 186. The whole assortment is now available to the Matas.dk customers  including customer communitaty in Matas kundeklub with more than 1,5 mill. Members.

Link to the products on Apopro: www.apopro.dk/brands/cannasen

Link to the products on Matas: www.matas.dk/cannasen

For more information about CS MEDICA, please contact:
Lone Henriksen, CEO
Phone: + (45) 71 20 30 47
Email: lh@galaxapharma.com
Website: https://www.cs-medica.com/

CS MEDICA A/S is a Danish medico cannabis company founded in 2011. CS MEDICA is committed to developing, manufacturing, and commercializing over-the-counter (OTC) medical device products containing cannabinoids. The Company runs its business through the two fully-owned subsidiaries, Galaxa Pharma A/S (distributor and representative of foreign manufacturers in the Nordic, registered medical device product distributor) and CanNordic A/S (Medical device developer and seller (BtB), registered medical device product manufacturer). CS MEDICA distributes products across the European borders and is headquartered in Copenhagen, Denmark.

The company is listed on Spotlight Stock Market in Stockholm (symbol: “CSMED”). For more information about CS MEDICA cs-medica.com.